Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
150 participants
OBSERVATIONAL
2021-04-01
2022-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
miRNAs in High Grade Serous Ovarian Cancer
NCT05146505
Biomarkers in Tissue Samples From Patients With Stage I or Stage III Endometrial Cancer
NCT01119573
Urinary miRNA in Endometrial Cancer Study
NCT03824613
The Role of POLE Mutation in High Risk Endometrial Cancer.
NCT07114653
Molecular Classification of Endometrial Cancer: Impact on Adjuvant Treatment Planning.
NCT06584630
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* histological diagnosis of endometrial cancer
* tumor resection
* patient's informed consent
Exclusion Criteria
18 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
IRCCS Azienda Ospedaliero-Universitaria di Bologna
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Anna Myriam Perrone
Principal investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Anna Myriam Perrone
Role: PRINCIPAL_INVESTIGATOR
IRCCS Azienda Ospedaliera-Universitaria di Bologna
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
IRCCS- Azienda Ospedaliera-Universitaria di Bologna
Bologna, Bo, Italy
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Anna Myriam Perrone
Role: CONTACT
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Anna Myriam Perrone, MD
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
189/2021/Oss/AOUBo
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.